- Report
- January 2022
- 278 Pages
Global
From €4077EUR$4,250USD£3,502GBP
Dilaudid is an opioid analgesic medication used to treat moderate to severe pain. It is a brand name for the generic drug hydromorphone, which is a semi-synthetic opioid derived from morphine. It is available in both immediate-release and extended-release formulations, and is typically administered orally, intramuscularly, or intravenously. It is commonly used in the treatment of chronic pain, post-operative pain, and cancer-related pain.
Dilaudid is part of the larger analgesic market, which includes both prescription and over-the-counter medications used to treat pain. This market includes a variety of drugs, such as non-steroidal anti-inflammatory drugs (NSAIDs), acetaminophen, opioids, and topical analgesics.
Companies in the Dilaudid market include Purdue Pharma, Endo Pharmaceuticals, and Mallinckrodt Pharmaceuticals. Show Less Read more